Fair-Value Report — Maxnerva Technology Services (1037.HK)

Insider Signal

Verified Market Snapshot

FX used throughout: 1 CNY ≈ 1.07 HKD (approximate August 2026 market rate; HKD pegged to USD ~7.78). All company financials reported in CNY unless noted. Prices in HKD.

Business Overview

Maxnerva Technology Services Limited (云智汇科技服务) is a Hong Kong-listed IT solutions group with operations predominantly in mainland China and limited international exposure (Europe, US, Taiwan, Singapore). The company has been a Foxconn (Hon Hai) affiliated entity for most of its listed life, providing technology services to the Foxconn manufacturing ecosystem and third parties in three segments:

• Smart Manufacturing: Factory IT systems, MES, IoT integration, AI-driven production automation — primarily serving Foxconn's own facilities and external manufacturers adopting Industry 4.0 processes.
• Smart Office: Enterprise software solutions, collaboration tools, and IT services for corporate clients.
• New Retail: Digital commerce infrastructure and omnichannel retail solutions.

Revenue history shows volatility: CNY 596M (2021) → CNY 832M (2022, peak) → CNY 678M (2023) → CNY 559M (2024, trough) → CNY 708M (2025, partial recovery). Three consecutive years of net losses (2023–2025) reflect high operating costs and competitive pricing pressure, though EBITDA remained marginally positive at CNY +24.9M in FY2025, confirming this is a D&A and investment burden rather than a fundamentally cash-negative business.

The company cited a "potential robotics collaboration" in September 2025, which triggered a speculative share rally from HKD 0.22 to HKD 1.42 (the 52-week high). The stock has since retraced sharply to the HKD 0.60–0.62 range as the robotics initiative appears to remain early-stage.

Valuation

Methodology

Maxnerva is a loss-making IT services company with three consecutive years of net losses and a recovery-stage revenue trajectory. A DCF is not appropriate (negative earnings, uncertain cash flow profile). The correct approach is:

1. Primary: P/B (Price-to-Book) with asset quality assessment — standard for loss-making service companies with identifiable balance sheet.
2. Secondary: EV/Revenue — sector cross-check.
3. MGO Offer Fairness Analysis — the bid price of HKD 0.6374 is the central reference; we assess whether it is fair, below, or above fundamental value.

Book Value & Asset Quality

FY2025 total equity: CNY 404.8M (≈ HKD 433M). Shares: 706.17M. Implied book value per share: CNY 0.573 ≈ HKD 0.614. Cross-checked against Investing.com's stated P/B of 0.92× at HKD 0.605, which implies book of HKD 0.658/share. The discrepancy likely reflects minor FX timing or residual items. We use HKD 0.658 as the stated book value per share (derived from reported P/B ratio, Investing.com, Aug 2026).

Asset quality notes:

• Total assets CNY 594M, equity CNY 405M → leverage ratio is low (D/E only 2.3%). Maxnerva is essentially debt-free.
• Current liabilities CNY 181.5M are primarily trade payables — operational, not financial.
• No visible goodwill impairment risk flagged in available data.
• EBITDA of CNY +24.9M suggests positive operating cash generation before capex.
• No going concern language found in available summary data (FY2025 annual results filed April 2026).

Implied P/B at MGO offer (HKD 0.6374): 0.6374 ÷ 0.658 = 0.97× P/B. Essentially at book value — no premium, no discount to NAV.

EV/Revenue Check

Market cap at offer: HKD 0.6374 × 706.17M = HKD 450M. Minimal debt (D/E 2.3% on CNY 405M equity ≈ CNY 9M net debt ≈ HKD 10M). Enterprise value ≈ HKD 460M. FY2025 revenue CNY 707.6M ≈ HKD 757M.

EV/Revenue = 0.61×. This is broadly in line with loss-making Chinese IT services peers (typically 0.4–0.8×). Not cheap, not expensive.

Scenario Valuation Table

Reverse Read

At HKD 0.6374 (the MGO price), the market implies Maxnerva is worth ~0.97× its stated book equity and 0.61× FY2025 revenue. To justify a higher price on a DCF basis, the company would need to return to CNY 25M+ net profit (last achieved in 2022) and sustain it — with a mid-teens WACC, that implies a revenue run-rate of CNY 900M+ at a 3.5% net margin, which is plausible but not demonstrated.

MGO Fairness Assessment

Under Hong Kong Takeovers Code Rule 26, the MGO price of HKD 0.6374 represents the highest price Foxconn (Far East) paid in the six months preceding the trigger date (July 27, 2026). Key considerations for minorities:

• Premium to market: +5.4% to HKD 0.605 (Investing.com, Aug 3 2026). Marginal premium.
• Discount to 52-week high: −55% to HKD 1.420. Substantial — but the high was driven by robotics collaboration speculation (Sept 2025) rather than fundamental value.
• vs. book value: 0.97× P/B — essentially at book. For a loss-making company, this is a standard (not generous) takeout multiple.
• Post-offer risk: If the MGO reaches >90% acceptance, Foxconn can compulsorily acquire remaining shares also at HKD 0.6374. If it reaches 50–90%, the company may remain listed with reduced free float and lower liquidity. If it fails to reach 50% (unlikely given Foxconn's 40.46% head-start), the stock could correct toward HKD 0.42–0.45.

Peer Comparison

Peer P/B and EV/Revenue are estimates based on available search data (Investing.com, Stockopedia, Aug 2026). Direct comparison is imperfect: Chinasoft is profitable and 24× larger; Digital China is an IT distributor with different economics. Maxnerva's MGO-price P/B of 0.97× is at the upper bound of what loss-making HK IT service companies typically trade at, suggesting the offer is at market rather than at a premium.

Conclusion & Rating

Key Risks

• MGO regulatory delay or complication: SFC approval is pending; any objection or restructuring requirement could delay the early-2027 timeline.
• MGO acceptance threshold: Foxconn must reach >50% to satisfy the condition. It holds 40.46% and needs ~9.5 percentage points more from the float. If acceptance is unexpectedly low, the offer lapses and the stock could correct sharply.
• Continued losses: If FY2026 performance deteriorates further (H1 2025 had a CNY −16.2M loss vs H1 2024 CNY −3.4M improvement), book value erodes and the offer becomes more attractive on a relative basis — but this signals fundamental weakness.
• Revenue concentration risk: Significant revenue dependence on Foxconn's own supply chain creates captive-customer risk; any Foxconn capex reduction flows directly to Maxnerva's top line.
• Macro and China IT spending: Weak enterprise IT spending in China would pressure all three segments.
• Intra-group signal opacity: FSK Holdings' role as a Hon Hai related party in this transaction reduces the signal quality. The net economic reality (external fund FDG exiting) is clear, but the structural complexity warrants caution.
• Post-MGO free float risk: If Foxconn achieves 50–89%, remaining minorities face illiquid trading conditions. The HK Exchange requires minimum 25% public float; Foxconn at 40.46% means 59.54% float currently, but any additional accumulation toward 75% triggers listing rule scrutiny.
• Data limitation: FY2025 annual report (filed April 2026) is the most recent audited source. Detailed segment revenue breakdown and cash position are not publicly available in machine-readable form; all balance sheet figures sourced from Investing.com's aggregation of HKEX filings.

Sources

• HKEX filing: Maxnerva FY2025 Annual Report (April 29, 2026) — www1.hkexnews.hk
• HKEX filing: Maxnerva H1 2025 Interim Results (August 20, 2025) — www1.hkexnews.hk
• Investing.com: 1037.HK financial summary and financial statements (accessed August 3, 2026)
• etnet.com.hk: 1037 stock data and shareholder structure (accessed August 3, 2026)
• Investing.com News: "Foxconn subsidiary to acquire Maxnerva shares, launch tender offer" (July 2026)
• Globe and Mail / TipRanks: "Foxconn Moves to Boost Control of Maxnerva with HK$152 Million Share Purchase and Tender Offer"
• Investegate (Hon Hai Precision regulatory announcement): "Acquire stock and the tender offer of Maxnerva"
• Yahoo Finance / CNBC: Market price data (accessed August 3, 2026)
• Peer data: Chinasoft International (354.HK), Digital China Holdings (861.HK) — Investing.com, Stockopedia, MarketScreener (accessed August 3, 2026)